Total Payments
$3,263
2024 Payments
$227.61
Companies
19
Transactions
165
Medicare Patients
2,341
Medicare Billing
$123,954
Payment Breakdown by Category
Food & Beverage$3,256 (99.8%)
Education$6.97 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,256 | 164 | 99.8% |
| Education | $6.97 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $809.39 | 40 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $438.32 | 24 | $0 (2024) |
| Amgen Inc. | $387.92 | 18 | $0 (2024) |
| Abbott Laboratories | $255.16 | 5 | $0 (2022) |
| Innovation Technologies Inc | $198.61 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $177.84 | 11 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $149.49 | 11 | $0 (2020) |
| PFIZER INC. | $132.35 | 9 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $126.00 | 6 | $0 (2019) |
| Astellas Pharma US Inc | $103.17 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $227.61 | 8 | Innovation Technologies Inc ($111.35) |
| 2023 | $134.85 | 5 | Innovation Technologies Inc ($54.38) |
| 2022 | $417.57 | 22 | Janssen Pharmaceuticals, Inc ($182.22) |
| 2021 | $39.47 | 3 | Janssen Pharmaceuticals, Inc ($25.03) |
| 2020 | $160.62 | 10 | Janssen Pharmaceuticals, Inc ($51.65) |
| 2019 | $689.39 | 40 | Janssen Pharmaceuticals, Inc ($144.89) |
| 2018 | $411.07 | 25 | Amgen Inc. ($97.20) |
| 2017 | $1,182 | 52 | Janssen Pharmaceuticals, Inc ($328.55) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 2 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/04/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/29/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/13/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/13/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/07/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/23/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/01/2022 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Structural Heart | ||||||
| 01/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/05/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/07/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: DIABETES | ||||||
| 09/17/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2020 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiology | ||||||
| 03/10/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/26/2020 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 02/20/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/20/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/23/2020 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Cardiology | ||||||
| 01/16/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/07/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Cardiovascular | ||||||
| 11/14/2019 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 542 | 641 | $90,239 | $21,813 |
| 2022 | 11 | 509 | 623 | $85,906 | $21,506 |
| 2021 | 13 | 550 | 632 | $120,285 | $28,807 |
| 2020 | 16 | 740 | 1,053 | $199,058 | $51,829 |
Total Patients
2,341
Total Services
2,949
Medicare Billing
$123,954
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 64 | 118 | $21,240 | $7,246 | 34.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 32 | $10,880 | $3,221 | 29.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 55 | 56 | $16,128 | $2,875 | 17.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 40 | $5,960 | $2,580 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 21 | $4,662 | $1,655 | 35.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 28 | 28 | $9,268 | $1,593 | 17.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 200 | 243 | $7,533 | $1,458 | 19.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 47 | $3,760 | $457.74 | 12.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 28 | 28 | $5,040 | $434.87 | 8.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 28 | 28 | $5,768 | $291.60 | 5.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 100 | $18,000 | $5,583 | 31.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 30 | $10,200 | $3,166 | 31.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 35 | $7,770 | $2,966 | 38.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 36 | $5,364 | $2,177 | 40.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 37 | 38 | $10,944 | $2,049 | 18.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 23 | $5,957 | $1,859 | 31.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 189 | 246 | $7,626 | $1,483 | 19.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 23 | 23 | $7,613 | $1,217 | 16.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 46 | 47 | $3,760 | $437.29 | 11.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 23 | 23 | $4,140 | $343.30 | 8.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2022 | 22 | 22 | $4,532 | $225.20 | 5.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 40 | 62 | $16,058 | $4,979 | 31.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 54 | 82 | $14,760 | $4,660 | 31.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 41 | 42 | $14,280 | $4,338 | 30.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 58 | $12,876 | $4,204 | 32.6% |
About Dr. Simon Chough, MD
Dr. Simon Chough, MD is a Cardiovascular Disease healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972575769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simon Chough, MD has received a total of $3,263 in payments from pharmaceutical and medical device companies, with $227.61 received in 2024. These payments were reported across 165 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,256).
As a Medicare-enrolled provider, Chough has provided services to 2,341 Medicare beneficiaries, totaling 2,949 services with total Medicare billing of $123,954. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Latrobe, PA
- Active Since 02/06/2006
- Last Updated 09/11/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1972575769
Products in Payments
- XARELTO (Drug) $809.39
- ENTRESTO (Drug) $355.07
- Corlanor (Drug) $271.49
- ELIQUIS (Drug) $257.19
- IRRISEPT (Device) $198.61
- PRALUENT (Drug) $152.77
- Absolute Pro vascular stent system (Device) $124.06
- Repatha (Biological) $116.43
- BRILINTA (Drug) $91.43
- PRALUENT (Biological) $84.27
- LEQVIO (Drug) $83.25
- PRADAXA (Drug) $82.85
- LEXISCAN (Drug) $77.71
- Xact carotid stent system (Device) $65.64
- Peripheral Orbital Atherectomy System (Device) $42.32
- PRALUENT ALIROCUMAB INJECTION (Biological) $41.73
- BioMonitor 2 (Device) $39.56
- Xience Alpine cornary stent system (Device) $36.76
- LifeVest (Device) $33.92
- Edora 8 DR-T (Device) $30.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Latrobe
Mark Milchak, Md, MD
Cardiovascular Disease — Payments: $8,261
Cardiovascular Disease $8,261
Abid Fakhri, M.d, M.D
Cardiovascular Disease — Payments: $1,593
Cardiovascular Disease $1,593
Salman Bhatti, M.d, M.D
Cardiovascular Disease — Payments: $1,506
Cardiovascular Disease $1,506
Subhashish Pal, M.d, M.D
Cardiovascular Disease — Payments: $926.49
Cardiovascular Disease $926.49
Edward Szabo
Cardiovascular Disease — Payments: $708.40
Cardiovascular Disease $708.40
Dr. Robert Staffen, Md, MD
Cardiovascular Disease — Payments: $313.17
Cardiovascular Disease $313.17